ORLANDO – At HIMSS24 on Tuesday, Dr. John Halamka, president of Mayo Clinic Platform offered a frank discussion about the substantial potential benefits – and very real potential for harm – in both predictive…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
Using Novel Digital Twins of Clinical Trial Participants, Unlearn is Accelerating Clinical Research to Help Bring New Treatments to Patients Sooner
Unlearn, an AI company creating digital twins of clinical trial participants that enable smaller,…
What You Should Know:
– Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round led by Kin, Contrary, and Footwork.
– The strategic funding fuels…
Continue Reading
Brian Williams, Life Sciences Strategy & Innovation at EPAM Systems, Inc.
Although the traditional nearly decade-long clinical trial timelines completely collapsed during COVID, this truncating was not necessarily novel. Precedent exists for accelerating approval timelines…
Continue Reading
Top News
ONC and The Sequoia Project designate Kno2 and CommonWell Health Alliance as Qualified Health Information Networks under TEFCA. They join Konza National Network, EHealth Exchange, Epic Nexus, Health Gorilla, and MedAllies, which were…
Continue Reading
Adam Goldberger, Chief Financial Officer at QuantHealth
Dr. Adam Petrick, MD, Chief Medical Officer at QuantHealth
What You Should Know:
What You Should Know:
– QuantHealth, an AI-powered clinical trial design company that simulates clinical trials, announced…
Continue Reading
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced it scored $50 million in Series C funding, bringing its total raise to more than $130 million. Altimeter Capital led the round with…
Continue Reading
What You Should Know: ObvioHealth, a global digital clinical trials company, and Oracle Life Sciences are expanding their partnership globally following the results of a year-long, successful effort launching trials in Asia Pacific.The collaboration will enable…
Continue Reading
